SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: A.J. Mullen who wrote (51971)7/26/2022 4:12:41 PM
From: Art Bechhoefer  Respond to of 52153
 
That's my point. The amyloid beta research is now suspect and many, if not most of the drugs in clinical trials have not proved very helpful. Even Biogen's aduhelm is effective only in the cases where Alzheimers is detected early. Ionis is the only biotech that I'm aware of that is looking into the effectiveness of its tau tangle antisense drug, which has proved effective in phases 1 -2.

Art